RE:RE:RE:RE:RE:Disheartening, really depressing, that share price is below Rome wasn't built in a day but I am hoping that the initiatives undertaken to get the patents and possible future deals will provide a boost to the bottom line in the short term. Still long and strong on this company but it would be nice to reap the rewards in my relative youth.
I am thinking that things will definately ramp up here. I won't be surprised to see multiple news releases within the Q1 financials that are pending. I'm putting my money on the positive results of Co-enzyme Q10 being found in the blood or lymph nodes of labratory animals and that they will be actively talking to multinational beverage companies to ink a licensing deal or deals.....if they haven't done so already. I also wouldn't be surprised if they announce a listing on a stock exchange outside Canada as per info released at the January presentation. Health Canada approval for the inflammation study will probably be released as well.
They keep their cards close to their chest and at least lately, seem to release information in clusters or in news releases just like they did in France when they announced the European patent. I'm okay with that.